Titin provides a molecular blueprint for muscle sarcomere assembly, and sarcomere length can vary according to titin isoform expression. If variations in sarcomere length influence muscle fascicle length, this may provide an advantage for running performance. Thus, the aim of this study was to investigate whether the titin (TTN) rs10497520 polymorphism was associated with muscle fascicle length in recreationally active men (RA; n=137) and marathon personal best time in male marathon runners (MR; n=141). Fascicle length of the vastus lateralis was assessed in vivo using B-mode ultrasonography at 50% of muscle length in RA.
| INTRODUCTION
The titin gene (TTN) encodes the largest described protein to date, which is the third most abundant protein within the myofilament of human striated muscle. 1 Titin provides a molecular blueprint for the assembly and organization of the thin and thick filaments during myofibrillogenesis. 2 Seven splice isoform variants of titin exist within human striated muscle, which each differ in size and elasticity.
1,2
A missense C>T transition (rs10497520), where the more common C-allele is replaced by the T-allele, has been identified within human TTN and reportedly contributes to the variability in the training response of maximal oxygen consumption (VO 2max ) in previously untrained individuals. 3 Within cardiac muscle, titin is suggested to be a key regulator of the Frank-Starling mechanism, 4 and considering the substantial differences in the elasticity of cardiac titin isoforms, 5 this C>T transition may contribute to the variability within titin isoform expression. Accordingly, differences in the titin isoforms expressed may explain the TTN-related increases in stroke volume 6 and consequently VO 2max following endurance exercise training. 3 Furthermore, if this TTN polymorphism influences titin isoform expression in cardiac muscle as speculated, there exists a distinct possibility that a similar influence is occurring within skeletal muscle tissue. In skeletal muscle, the predominant titin isoform is N2A, of which smaller (T1) and larger (T2) isovariants exist within humans. 7 A recent study, which identified a TTN mutation that alters isoform splicing in rats, demonstrated an association between isoform size and sarcomere length, with significantly longer resting sarcomere lengths corresponding to the larger mutant titin isoforms. 8, 9 Assuming a linear relationship between fascicle length and in series sarcomere number, 10 it follows that fascicles expressing larger titin isoforms could be longer than those expressing smaller titin isoforms. It is important to note, however, that there was no association between titin isoform size and resting sarcomere length in wild-type rats, those without the larger mutant titin isoform in the aforementioned study. 8 Furthermore, evidence exists demonstrating the non-uniform distribution of sarcomere length within fascicles of the same muscle and different muscles 11, 12 ; thus, understanding the potential influence of titin on skeletal muscle architecture in humans appears complex.
If TTN-dependent differences in skeletal muscle fascicle length are apparent, variability in muscle functional phenotypes might also be expected. For instance, muscle maximal shortening velocity (V max ) is positively correlated with fascicle length. 13, 14 Although no direct associations between TTN and fascicle length have been reported, the aforementioned C>T transition within the TTN gene has been identified as contributing significantly to a genetic predisposition for maximal isokinetic strength at 180°·s −1 but not 60°·s
15 which could indirectly demonstrate that variability in V max is influenced by genotype-dependent differences in fascicle length. Furthermore, enhanced efficiency of stretch-shortening contractions can be expected in individuals possessing shorter muscle fascicles due to the lower metabolic cost of producing a given force. More specifically, shorter fascicles produce the same force per unit cross-sectional area as longer fascicles, but when producing a given force, a smaller volume of muscle is activated in individuals possessing shorter fascicles. 16, 17 Accordingly, vastus lateralis fascicle length and gastrocnemius muscle fascicle length are shorter in elite distance runners than elite sprinters and untrained controls, and longer in elite sprinters than untrained controls. 18 Shorter fascicles in elite distance runners are likely to contribute to improved mechanical efficiency, whereas the longer fascicles observed in elite sprinters are likely to contribute to enhanced V max . To date, however, it remains unclear whether these differences in the muscle architecture of elite runners are the result of adaptations to training or genetic variation.
Consequently, this study aimed to investigate whether the TTN rs10497520 polymorphism was associated with muscle fascicle length in recreationally active men, and to investigate whether TTN genotype distribution differed between recreationally active men and trained male marathon runners. It was hypothesized that the TTN polymorphism would be associated with muscle fascicle length in recreationally active men, and the genotype associated with shorter fascicle length in this population would be overrepresented in trained marathon runners. , self-reported as having a known musculoskeletal or neurological disorder and/or had undertaken any structured training in the preceding 12 months. MR participants comprised Olympic-, international-and national-level marathon runners and were included if they had achieved marathon personal best times under 2 hours 36 minutes (range ~2 hours 7 minutes to ~2 hours 35 minutes). MR participants were primarily recruited from London Marathon competitors at the London Marathon Expos during 2013-2015 and regional athletics clubs and organizations via mail-outs, posters and word of mouth. All participants gave written informed consent to participate in this study, which received approval from the Ethics Committee of Manchester Metropolitan University and complied with the Declaration of Helsinki.
| MATERIALS AND METHODS
Muscle fascicle length of the vastus lateralis (VL) was measured in vivo using B-mode ultrasonography (AU5, Esaote, Florence Italy) for each RA participant. VL muscle length of the right limb was measured at rest following identification of the VL origin and insertion, while participants were standing upright with knees extended and relaxed. 18 While in this position, ultrasound scans were taken at 50% of VL muscle length, in the mid-sagittal plane, using a 40 mm wide, 7.5-MHz linear-array probe positioned perpendicular to the skin. Although the knee joint angle during standing does not correspond to that of optimal force production during running, 19, 20 measurement of fascicle length in this position is highly reproducible. Each ultrasound scan was recorded using a 25-Hz sampling frequency in audio video interleave (AVI) format, and frame-capture software (Adobe Premiere Elements version 10, Adobe Systems) was used to capture single images for subsequent analysis. The distance between
fascicular origin in the lower aponeurosis and insertion in the upper aponeurosis was measured as fascicle length using digitizing software (NIH ImageJ, version 1.44o, National Institute of Health, Bethesda, Maryland). Measurement of fascicle length in all instances required extrapolation of the superficial and deep aponeuroses to allow for estimation of fascicle length, due to fascicles extending beyond the ultrasound field of view. 21 For each participant, a minimum of three fascicles were measured and a mean of these was taken as fascicle length. Due to the field-based nature of data collection within MR, it was not possible to obtain measurements of fascicle length in this population. All participants provided either a blood, saliva or buccal cell sample using the following protocols. For blood sampling, a 5-mL sample was taken from a superficial forearm vein into EDTA tubes (BD Vacutainer Systems, Plymouth, UK) and stored at −20°C. Saliva samples were collected following a minimum 30-minute abstinence from food and drink into Oragene DNA OG-500 collection tubes (DNA Genotek Inc., Ottawa, Ontario, Canada) in accordance with the manufacturer's guidelines and stored at room temperature. Buccal cell samples were collected in duplicate (Whatman Sterile, OmniSwab, GE Healthcare, Little Chalfont, Buckinghamshire, UK) following a minimum 1-hour abstinence from food and drink. Participants were instructed to brush one OmniSwab collection tip firmly against the inside of the cheek for approximately 30 seconds and repeat with a second swab on the opposite cheek. Each collection tip was ejected into a 2-mL microcentrifuge tube and stored at −20°C.
The Qiagen QIAcube spin protocol (Qiagen, Crawley, UK), used for the extraction of genomic DNA from whole blood, saliva and buccal cell samples, was completed in accordance with the manufacturer's guidelines and used the buffers contained in the Qiagen DNA Blood Mini Kit. Each participant was genotyped for the TTN rs10497520 polymorphism, using real-time PCR on 96-well plates. The 10 μL reaction volume, for genotyping using DNA obtained from whole blood or saliva samples, contained 0. DNA amplification (StepOnePlus Real-Time PCR System, Applied Biosystems) was completed using the following protocol: an initial 10 minutes at 95°C followed by 40 cycles of denaturation for 15 seconds at 92°C, primer annealing and extension for 1 minute at 60°C and plate read. TTN genotype was subsequently determined using StepOnePlus analysis software version 2.3 (Applied Biosystems). Genotypes were called based on reporter dye intensity and visualized using cluster plots. The TaqMan assays included VIC and FAM dyes that for rs1049752 indicated C-and T-alleles on the forward DNA strand, respectively. Thus, VIC and FAM were interpreted as: 5′-TCCAACTT[C/T]AGGTTCTT-3′. All samples were analyzed in duplicate, and 100% agreement between all duplicate samples was achieved.
Genotype frequency of the TTN rs10497520 polymorphism was assessed for compliance with Hardy-Weinberg equilibrium using a chi-square test. Due to the low number of TT homozygotes in the whole sample (RA, n=0; MR, n=1), CC homozygotes were compared to T-allele carriers within each subgroup (RA, CC vs CT; MR, CC vs CT+TT). Independent samples t tests were conducted to determine any significant differences in physical characteristics (height, mass, BMI and age) between RA and MR, and according to genotype. Additionally, independent samples t tests were conducted to identify any genotype differences in fascicle length in RA and marathon personal best time in MR. Pearson's chi-square tests were used to compare genotype frequencies between MR and RA. All statistical analyses were performed using SPSS version 21 (Armonk, New York, USA), and alpha was set at 0.05. Data are presented as mean (SD) unless otherwise stated.
| RESULTS
Genotype frequency of the TTN rs10497520 polymorphism was in Hardy-Weinberg equilibrium for the whole sample and both the RA and MR subgroups (Table 1) . MR were older and had lower mass (~9 kg) and BMI than RA (all differences P≤1.0×10 −13 ), but there was no difference in height (P=.660). Genotype was not associated with mass, BMI or height either within the RA or MR subgroups, nor in the combined sample of 278 participants (P≥.376; Table 1 ).
In the RA subgroup, VL fascicle length was 10.4% longer in CC homozygotes than in CT heterozygotes (P=.003; Figure 1 ). Furthermore, when VL fascicle length was normalized to VL muscle length, VL fascicle length remained significantly longer in CC homozygotes than in CT Figure 2 ].
| DISCUSSION
The aims of the present study were to investigate whether VL muscle fascicle length was associated with TTN rs10497520 genotype in recreationally active Caucasian men and to identify whether differences in genotype frequency were evident between recreationally active individuals and trained marathon runners. This study is the first to show a genetic influence on muscle architecture; specifically, the results demonstrate that VL muscle fascicle length was significantly longer in TTN CC homozygotes compared to CT heterozygotes in RA. This is also the first time marathon performance in trained runners was associated with TTN genotype, with T-allele carriers performing significantly better than CC homozygotes. Titin acts as a template for myofibrillar protein assembly during sarcomere formation and provides an attachment site for a plethora of myofibrillar proteins to maintain the structural integrity of the sarcomere. 2 This protein is therefore likely to play a key role in the architecture of skeletal muscle, possibly affecting the serial arrangement of sarcomeres and, therefore, the length of muscle fascicles. 8, 9 Mean VL fascicle length in the RA group [7.1 (1.5) cm] was comparable to some previous reports of VL fascicle length (~7 cm), 18, 22 but less than others (~8 cm and ~9 cm). 23, 24 Differences in participant positioning and muscle activation during the measurement of muscle fascicle length are likely to explain the reported differences between the present study and reports elsewhere. 22 Indeed, VL fascicle length was measured during standing with the knees extended and relaxed in the present study, which was similar to those studies reporting comparable fascicle lengths. 18, 22 Those studies observing longer muscle fascicle lengths positioned the knee at 60-90° flexion and obtained measurements during maximal voluntary contraction.
23,24
The TTN genotype and allele frequencies observed in the present study were similar to previous reports in Caucasian populations (www.hapmap.org). 25 In the present study, individuals homozygous for the major C-allele had longer VL fascicles than heterozygotes, but as no individuals homozygous for the minor T-allele were present in the RA group, reflective of the low frequency of the T-allele within a Caucasian population, it is unclear whether the VL fascicles of TT homozygotes would have been smaller still. Future research should attempt to replicate the observed association between TTN and fascicle length on larger cohorts that include a sufficient number of TT homozygotes. Based on the T-allele frequency we observed, future studies would require 2000 participants to recruit 20 TT homozygotes. A "stressthe-genotype" approach 26 could help prioritise recruitment of TT homozygotes prior to conducting time-consuming phenotype assessments. Furthermore, as fascicle length is known to vary between muscles, 23,27,28 future research should also include measurements of fascicle length from multiple muscles (ie, gastrocnemius and soleus) to establish whether the observed association with TTN genotype is consistent across different muscle groups, or specific to the vastus lateralis. Nonetheless, it is possible that the presence of the T-allele affects TTN splicing thus increasing expression of a smaller titin isoform within the muscle fascicles of heterozygotes. To date, seven different titin splice isoforms have been identified within human striated muscle that each differ in size. 1 Within human skeletal muscle, the predominant titin isoform is N2A, of which two isovariants (T1 and T2) are known to exist. 7 Thus, it is possible that altered TTN splicing, due to the presence of the T-allele, may influence the expression of these N2A isovariants and might explain the current observations. Earlier studies in rat cardiac muscle support these possibilities by demonstrating a link between a TTN mutation and alternative isoform splicing 11 and, more recently, TTN was associated with both cardiac and skeletal muscle sarcomere length in rats. 8, 9 Individuals with longer fascicles (CC homozygotes) would in theory experience a rightward shift in their length-tension relationship and, potentially, larger optimal joint angles for maximal torque production. Such a shift in the length-tension relationship has been linked to a reduction in injury occurrence, as a longer optimum muscle length would ensure that less of the muscle's functional range would be along the more unstable descending limb of the length-tension curve. 29 Thus, in populations at increased risk of injury, such as athletes, it may be necessary to tailor training interventions specific to TTN genotype. Considering the observed association between TTN genotype and VL fascicle length, it was hypothesized that Tallele carriers would be overrepresented in habitually trained marathon runners because shorter fascicles require less energy to produce a given force, which is likely to contribute to improved mechanical efficiency in this population. 16 No difference, however, in TTN genotype distribution was observed between the RA and MR groups. Nonetheless, the MR T-allele carriers (those expected to possess shorter fascicles according to our RA data) had marathon personal best times 2 minutes 25 seconds faster than MR CC homozygotes. This observation is consistent with previous reports of elite distance runners possessing shorter fascicles than both untrained individuals and elite sprinters. 18 Thus, possession of the T-allele, while not essential for successful marathon running performance, might convey an advantage for marathon running when combined with appropriate training and nutritional regimens as could be expected of the habitually trained runners included in the present study. Despite observing associations between TTN genotype and VL fascicle length in RA and marathon personal best time in MR, it remains unclear whether marathon personal best time was enhanced in the MR T-allele carriers as a consequence of possessing a shorter fascicle length, as this was not directly measured in the MR group. As titin is suggested to be a key regulator of the Frank-Starling mechanism, the influence of TTN within cardiac muscle could provide an alternative explanation for the observed association between TTN genotype and MR personal best time. TTN-related increases in stroke volume following endurance training have been observed previously 6 and the rs10497520 polymorphism appears to contribute to the training response of VO 2max in previously untrained individuals. 3 Interestingly, however, 32 Moreover, improved running economy in individuals possessing lower ratios of titin isoforms (T1/T2) has recently been reported, 33 although more research is required to investigate whether the rs10497520 T-allele corresponds to lower T1/T2 ratios. Thus, despite a potential pleiotropic influence of TTN on both cardiac and skeletal muscle, possession of the T-allele (and consequently shorter VL fascicles) appears more important for marathon performance in trained individuals. Finally, as RA CC homozygotes possessed longer VL fascicles, an association of this genotype with successful sprint running performance is possible. Longer muscle fascicles are known to contribute to enhanced V max , 13, 14 which is an important determinant of sprint performance. 34 Thus, trained sprinters with the CC genotype might possess longer muscle fascicles and enhanced sprint ability compared to trained sprinters carrying the T-allele. Future research should investigate the impact of TTN genotype on sprint performance in addition to running economy, mechanical efficiency and V max , to enhance our understanding of these associations.
| CONCLUSION AND PERSPECTIVE
Here we report, for the first time, a genetic influence on human skeletal muscle architecture. The T-allele at the rs10497520 polymorphism in TTN, the gene encoding the giant structural protein titin, is associated with shorter VL muscle fascicles in recreationally active men, and faster marathon performance (nearly 2.5 minutes faster) in habitually trained male runners with personal best times of approximately 2.5 hours. Considering shorter muscle fascicles require less energy to produce a given force, the genotype-dependent differences in marathon personal best times may be due to differences in mechanical efficiency between T-allele carriers and CC homozygotes.
